Medicine and Health

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

P. A. Weidenbacher, M. Sanyal, et al.

Introducing DCFHP-alum, a groundbreaking ferritin-based COVID-19 vaccine that shows remarkable promise for global accessibility! Developed by a team of experts including Payton A.-B. Weidenbacher and Prabhu S. Arunchalam from Stanford University, this vaccine generates robust and lasting neutralizing antibodies against various SARS-CoV-2 variants and even SARS-CoV-1. With its impressive stability and potential for high-yield production, it could serve as a yearly booster or primary pediatric vaccine.